Keyphrases
Malaria
100%
Desferrioxamine
100%
Iron Chelator
100%
Polymeric Device
100%
Slow Drug Release
100%
Parasitemia
50%
Salicylhydrazone
50%
First-order
25%
Consecutive Days
25%
IC50
25%
Blood Levels
25%
Reduced Mortality
25%
Hydrophilic Drug
25%
Neurological Sequelae
25%
Lipophilic
25%
Drug Release
25%
Slow Release
25%
Drug Administration
25%
Polymer Implants
25%
Post-infection
25%
Iron Overload
25%
Antimalarial Activity
25%
Plasmodium Falciparum
25%
Overload Conditions
25%
In Vitro Proliferation
25%
Plasmodium Vinckei
25%
Lipophilic Drugs
25%
Cerebral Malaria
25%
Swiss Albino Mice
25%
Iron Chelation Therapy
25%
Plasmodium Berghei K173
25%
Parasite Proliferation
25%
In Vivo Assessment
25%
Malaria Chemotherapy
25%
Suggested Model
25%
Release Devices
25%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Release
100%
Deferoxamine
100%
Iron Chelating Agent
100%
Mouse
50%
Hydrazone Derivative
50%
Salicylaldehyde
50%
Parasitemia
50%
Chelation Therapy
25%
Drug Administration
25%
Chemotherapy
25%
Iron Poisoning
25%
Plasmodium berghei
25%
Implant
25%
Swiss Webster Mouse
25%
Plasmodium vinckei
25%
Plasmodium falciparum
25%
Antimalarial Agent
25%
Cerebral Malaria
25%
IC50
25%